Tag: Patents
Federal Circuit Narrows “Consisting Essentially Of” in Eye Therapies v. Slayback Pharma Patent Dispute
June 30, 2025
Eye Therapies, LLC v. Slayback Pharma, LLC Authored by: Jeremy J. Gustrowsky In a significant decision for patent claim interpretation, the Federal Circuit recently reversed a Patent Trial and Appeal Board (PTAB) ruling in Eye Therapies, LLC v. Slayback Pharma,…
Read MoreFederal Circuit Affirms Dismissal of Mitek’s Declaratory Judgment Suit Against USAA Over Mobile Banking Patents
June 12, 2025
Mitek Sys. v. United Servs. Auto. Ass’n Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed the dismissal of a declaratory judgment action brought by Mitek Systems, Inc. against United Services Automobile Association (USAA) regarding four…
Read MorePatent Owner’s Silence Not Enough: Federal Circuit Revives Fraunhofer’s Patent Suit Against Sirius XM
June 9, 2025
Fraunhofer-Gesellschaft Zur F_rderung Der Angewandten Forschung E.V. v. Sirius XM Radio Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit reversed a district court’s ruling that had blocked Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung E.V. from…
Read MoreWho Can Appeal a Patent Board Decision? Dolby Labs Learns the Limits
June 5, 2025
Dolby Labs. Licensing Corp. v. Unified Pats., LLC Authored by: Jeremy J. Gustrowsky The Federal Circuit recently dismissed an appeal by Dolby Laboratories Licensing Corporation, clarifying when a party can challenge a Patent Trial and Appeal Board (PTAB) decision in…
Read MorePatent Lexicography Takes Center Stage in Alnylam v. Moderna COVID-19 Vaccine Dispute
June 4, 2025
Alnylam Pharms., Inc. v. Moderna, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed a district court’s ruling in the high-profile patent dispute between Alnylam Pharmaceuticals, Inc. and Moderna, Inc. over Moderna’s COVID-19 vaccine, SPIKEVAX®.…
Read MoreFederal Circuit Clarifies Patent Claim Scope in X-Ray Imaging Dispute
May 23, 2025
Sigray, Inc. v. Carl Zeiss X-Ray Microscopy, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit addressed the proper interpretation of patent claims relating to X-ray imaging technology, specifically focusing on U.S. Patent No. 7,400,704, owned…
Read MoreUnderstanding Patents vs. Copyrights: Safeguarding Your Creative Ideaslaw
May 14, 2025
When it comes to protecting your creative ideas, understanding the difference between a patent and a copyright is crucial. A patent is a legal right granted by the government, allowing the inventor to exclude others from making, using, selling, or…
Read MoreWho Really Invented CRISPR for Eukaryotic Cells? Federal Circuit Weighs In
May 12, 2025
Regents of the Univ. of Cal. v. Broad. Inst., Inc Authored by: Jeremy J. Gustrowsky The long-running patent dispute over who first invented the CRISPR-Cas9 gene-editing technology for use in eukaryotic cells—those found in plants, animals, and humans—took another turn…
Read MoreStanding Roadblock: Incyte’s Patent Appeal Dismissed for Lack of Concrete Plans
May 7, 2025
Incyte Corp. v. Sun Pharm. Indus., Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit dismissed Incyte Corporation’s appeal in its patent dispute with Sun Pharmaceutical Industries, Inc., highlighting the strict requirements for Article III standing…
Read MorePatent Invalidity Upheld: Public Use and IPR Estoppel Clarified in Ingenico v. IOENGINE
May 7, 2025
Ingenico Inc. v. Ioengine, LLC Authored by: Jeremy J. Gustrowsky In a significant decision for patent law, the Federal Circuit affirmed a jury verdict that found several claims of IOENGINE’s patents invalid, providing important guidance on what counts as “public…
Read MorePatent Reissue Claims: Federal Circuit Says Actual Claim Language, Not Inventor Intent, Controls Scope
May 6, 2025
In re Kostic Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit clarified an important rule for patent owners seeking to broaden their claims through a reissue: what matters is the actual language of the original claims,…
Read MoreCourt Limits Patent Injunctions on Clinical Trials and FDA Applications in Jazz v. Avadel
May 6, 2025
Jazz Pharms., Inc. v. Avadel CNS Pharms., LLC Authored by: Jeremy J. Gustrowsky A recent decision in Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC provides important guidance on how far patent owners can go in blocking competitors from conducting…
Read More